Missing a dose can affect appetite control and slow progress depending on timing and frequency
Spironolactone can interfere with lab results and cause false test results
GLP-1s are approved for weight loss in adults who have a body mass index of 30 or higher, and those who are overweight with a body mass index of 27 or higher with at least one weight-related health condition such as high blood pressure, high cholesterol and type 2 diabetes
The drugs may also help reduce systemic inflammation, which is when the bodys immune system goes into overdrive trying to protect it from false threats
NICE guideline CG189 (Obesity: identification, assessment and management) recommends that prescription-strength orlistat 120 mg be considered for adults with a BMI of 30 kg/m or above, or 28 kg/m or above in the presence of weight-related risk factors such as type 2 diabetes or hypertension, within a structured weight management programme
310,311 GLP-1RAs also enhance autophagy, a process of cellular clearance of damaged and outdated components